Skip to content
Get BIO’s view on everything from health care to biofuels and the bioeconomy. The below articles include BIO statements, opinion, and calls to action, as well as articles and op-eds written by BIO leadership.
The Biotechnology Innovation Organization (BIO) announced this year’s winners of awards in agricultural, environmental, and industrial biotechnology, the organization said in a press release. […]
BIO awards two biotech leaders for contributions to agriculture Read More »
New rules for applying for federal SBIR/STTR seed funding will be explained by members of the NIH office reviewing applications in a Sept. 19
BIO webinar offers expert advice on applications for SBIR/STTR grants Read More »
Rachel King, the CEO of the Biotechnology Innovation Organization (BIO), shares insights about drug price controls and other challenges to the biotech industry that
BIO’s Rachel King weighs in on IRA and the biotech industry in new podcasts Read More »
The Federal Trade Commission (FTC) on Sept. 1 settled a lawsuit that was threatening to “chill investment, with predictable and unwelcome results for innovation
FTC settles suit that would have been harmful to biotech innovation Read More »
Using organic social sharing techniques and tools, BIO’s social media team was able to drive record levels of engagement for their premier event. For
On August 4, U.S. lawmakers introduced two new bills in an effort to further strengthen the Vaccine Injury Compensation Program (VICP) and help the
House introduces bills to strengthen Vaccine Injury Compensation Program (VICP) Read More »
Photo: BIO’s Emily Wheeler (second from left) with Jean Mwale, Amputee Coalition regional ambassador and sepsis survivor (right), at the Amputee Coalition 2023 National
How amputees give voice to AMR Read More »
Voters hold a favorable opinion of biotechnology and support streamlined government regulatory processes to allow faster approval of biotech innovations in agriculture, according to
Creative individuals are spearheading imaginative approaches as biotech battles cancer, the leading cause of death worldwide. Profiles of leaders from a cancer institute and
Innovators describe biotech advances against cancer in I am BIO videos Read More »
The 340B Program has grown exponentially as hospitals take advantage of the opportunity to profit from drug discounts while the low-income and uninsured patients
BIO tells Senators the 340B program needs reforms so it helps patients Read More »
